Tìm kiếm
XORTX Therapeutics Inc
XRTXThêm vào danh sách theo dõi
1.760USD
-0.100-5.38%
Giờ giao dịch 09/23, 10:12（ET）
3.20MVốn hóa
LỗP/E TTM
Giới thiệu về XORTX Therapeutics Inc Công ty
XORTX Therapeutics Inc. is a pharmaceutical company. The Company is engaged in developing medications that improve the quality of life and health of individuals with gout and other important diseases. It has three clinically advanced products in development: its lead program, XRx-026 program for the treatment of gout; XRx-008 program for autosomal dominant polycystic kidney disease (ADPKD); and XRx-101 for acute kidney and other acute organ injury associated with respiratory virus infections. In addition, the Company is developing XRx-225, a pre-clinical stage program for Type II diabetic nephropathy. It is working to advance products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit the production of uric acid. The XRx-026 program is designed to decrease the chronically high serum uric acid concentration in the blood (SUA) by inhibiting the production of uric acid by the xanthine oxidase enzyme by administering a xanthine oxidase inhibitor-oxypurinol.
XORTX Therapeutics Inc Hồ sơ
Mã chứng khoánXRTX
Tên công tyXORTX Therapeutics Inc
Ngày IPOSep 30, 2015
Giám đốc điều hànhDavidoff (Allen W)
Số lượng nhân viên2
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhSep 30
Địa chỉ3710 - 33rd Street NW
Thành phốCALGARY
Sàn giao dịch chứng khoánNASDAQ OMX - NASDAQ BASIC
Quốc giaCanada
Mã bưu điệnT2L 2M1
Điện thoại14034557727
Trang webhttps://www.xortx.com/
Mã chứng khoánXRTX
Ngày IPOSep 30, 2015
Giám đốc điều hànhDavidoff (Allen W)
Lãnh đạo công ty của XORTX Therapeutics Inc
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Ms. Krysta Davies Foss
Ms. Krysta Davies Foss
Director
Director
554.00
--
Ms. Krysta Davies Foss
Ms. Krysta Davies Foss
Director
Director
554.00
--
Dr. Allen W. Davidoff, Ph.D.
Dr. Allen W. Davidoff, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Paul J. Van Damme
Mr. Paul J. Van Damme
Independent Director
Independent Director
--
--
Dr. Stephen Haworth
Dr. Stephen Haworth
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Raymond Dennis (Ray) Pratt, M.D.
Dr. Raymond Dennis (Ray) Pratt, M.D.
Independent Director
Independent Director
--
--
Mr. Stacy Evans, M.D.
Mr. Stacy Evans, M.D.
Chief Business Officer
Chief Business Officer
--
--
Mr. Michael Bumby
Mr. Michael Bumby
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mika Grasso
Mr. Mika Grasso
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
--
Mr. Depesh Narotam
Mr. Depesh Narotam
Independent Director
Independent Director
--
--
Xem thêm
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Ms. Krysta Davies Foss
Ms. Krysta Davies Foss
Director
Director
554.00
--
Ms. Krysta Davies Foss
Ms. Krysta Davies Foss
Director
Director
554.00
--
Dr. Allen W. Davidoff, Ph.D.
Dr. Allen W. Davidoff, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Paul J. Van Damme
Mr. Paul J. Van Damme
Independent Director
Independent Director
--
--
Dr. Stephen Haworth
Dr. Stephen Haworth
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Raymond Dennis (Ray) Pratt, M.D.
Dr. Raymond Dennis (Ray) Pratt, M.D.
Independent Director
Independent Director
--
--
Câu hỏi thường gặp
Ai là năm cổ đông lớn nhất của XORTX Therapeutics Inc?
Năm cổ đông hàng đầu của XORTX Therapeutics Inc là: Ms. Krysta Davies Foss